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The canonical Wnt-b-catenin signaling pathway is initiated by inducing phosphorylation of one of the Wnt receptors, low-density lipoprotein receptor-related protein 6 (LRP6), at threonine residue 1479 (Thr 1479 ) and serine residue 1490 (Ser 1490 ). By screening a human kinase small interfering RNA library, we identified phosphatidylinositol 4-kinase type II a and phosphatidylinositol-4-phosphate 5-kinase type I (PIP5KI) as required for Wnt3a-induced LRP6 phosphorylation at Ser 1490 in mammalian cells and confirmed that these kinases are important for Wnt signaling in Xenopus embryos. Wnt3a stimulates the formation of phosphatidylinositol 4,5-bisphosphates [PtdIns (4,5)P 2 ] through frizzled and dishevelled, the latter of which directly interacted with and activated PIP5KI. In turn, PtdIns (4,5)P 2 regulated phosphorylation of LRP6 at Thr 1479 and Ser 1490 . Therefore, our study reveals a signaling mechanism for Wnt to regulate LRP6 phosphorylation. M embers of the Wnt family of secretory glycoproteins have important roles in various physiological and pathophysiological processes, including embryonic de-velopment, bone development, neuronogenesis, adipogenesis, myogenesis, organogenesis, lipid and glucose metabolism, and tumorigenesis (1) (2) (3) (4) (5) . Canonical Wnt binds to two receptors, lipoprotein receptor-related protein 6 (LRP6) and frizzled (Fz) proteins, leading to phosphorylation of LRP6 at Thr 1479 by casein kinase 1g and at Ser 1490 by glycogen synthase kinase 3 (GSK3) (6) (7) (8) (9) (10) . Wnt appears to regulate Thr 1479 phosphorylation by inducing the formation of LRP6 aggregates (9), whereas it regulates Ser 1490 phosphorylation through GSK in an axin-dependent manner (10) .
To determine whether there are other kinases that take part in the regulation of LRP6 phosphorylation, we screened a human kinase small in- terfering RNA (siRNA) library from Applied Biosystems for effects on Wnt-induced accumulation of cytosolic b-catenin detected by an enzyme-linked immunosorbent assay (ELISA) and on phosphorylation of Ser 1490 of LRP6 detected by protein immunoblotting in human embryonic kidney (HEK) 293T cells (11). Multiple phosphatidylinositol (PtdIns) kinase siRNAs inhibited cytosolic b-catenin accumulation (fig. S1A and table S1) and the phosphorylation of LRP6 at Ser 1490 (Fig. 1, A and B ) in response to purified Wnt3a protein. Among the tested PtdIns kinase siRNAs, siRNAs for phosphatidylinositol 4-kinase type II a (PI4KIIa) and phosphatidylinositol-4-phosphate 5-kinase type I b (PIP5KIb) had the strongest inhibitory effects (Fig. 1, A and B, and fig. S1A ). These siRNA also inhibited Wnt3a-induced reporter gene activity (fig. S1B). Additional siRNAs for both PI4KIIa and PIP5KIb directed against different targeting sequences were also tested ( Fig. 1, A and B, and fig. S1, B and C). To further verify that the effects of these siRNAs were specific, we restored Wnt signaling by expressing the kinases knocked down by the siRNAs (fig. S1, D to G). PI4KIIa and PIP5KIb siRNAs did not inhibit lithium-and axin1/2 siRNAinduced accumulation of b-catenin, but b-catenin siRNA did (fig. S1, C and H). Thus, these siRNAs appeared to affect Wnt signaling by affecting LRP6 phosphorylation rather than Wnt signaling downstream components.
PIP5KIg siRNAs also showed a weak inhibitory effect, whereas PIP5KIa siRNAs had no effect in HEK293T cells ( Fig. 1B) . However, treatment of the cells with combinations of the PIP5KI siRNAs showed that the combination targeting all three PIP5KI isoforms reduced Wnt3a-indcued accumulation of b-catenin and phosphorylation of LRP6 almost to basal levels (fig. S1, C and I), suggesting that PIP5KIa and 1g may also contribute to Wnt signaling in these cells.
We next examined the roles of the PtdIns kinases in Wnt signaling with the use of Xenopus embryos. A morpholino (MO) targeting Xenopus PI4KIIa inhibited XWnt8-induced, but not bcatenin-induced, axis duplication in Xenopus embryos ( Fig. 1C and fig. S2A ). Although PIP5KIb MO showed little effect, a MO targeting its close homolog PIP5KIa inhibited XWnt8-induced, but not b-catenin-induced, axis duplication ( Fig. 1D ). Consistent with the phenotypes, PIP5KIa and PI4KIIa MOs reduced phosphorylation of LRP6 ( fig. S2B ). In addition, the expression of catalyt-ically inactive PIP5KIa and PI4KIIa mutants suppressed axial duplication induced by XWnt8, but not by b-catenin ( fig. S2C ), further confirming the importance of these kinases in Wnt signaling.
Inhibition of zygotic Wnt-b-catenin signaling induces anteriorized phenotypes that include enlarged cement glands and head structures (12). PI4KIIa MO that was injected into the dorsal regions of Xenopus embryos induced strong anteriorized phenotypes in more than 70% of embryos. This effect could be partially reversed by coinjection of Xenopus PI4KIIa mRNA ( Fig. 1E  and fig. S2D ). Although PIP5KIa MO had little effect on the phenotype, PIP5KIb MO induced anteriorized phenotypes in~50% of the treated embryos. The PIP5KIb MO effect could be almost completely reversed by the injection of XPIP5KIb mRNA ( Fig. 1E and fig. S2D ). Together, these results indicate that PtdIns kinases regulate endogenous Wnt signaling in Xenopus embryos.
Because sequential phosphorylation of PtdIns lipids by PI4KII and PIP5KI constitutes the major pathway for PtdIns (4,5)P 2 production in most cells (13, 14) , we suspected that PtdIns (4,5)P 2 might regulate the phosphorylation of LRP6 at Ser 1490 . To test this hypothesis, we delivered PtdIns, plus all of the seven possible isoforms of PtdIns phosphates at equal molar concentrations, into HEK 293T cells in a lipid carrier. PtdIns (4,5)P 2 showed the strongest stimulatory effect on Wnt3a-induced phosphorylation of Ser 1490 ( Fig. 2A ). In addition, the delivery of PtdIns (4)P (but not PtdIns) rescued the effect of PI4K siRNA, whereas the delivery of PtdIns (4,5)P 2 (but not PtdIns (4)P) rescued the effect of PIP5K siRNA on Wnt3a-induced phosphorylation of LRP6 (Fig. 2, B and C) and b-catenin accumulation ( fig. S3 ). These results suggest that PtdIns (4,5)P 2 may be the primary PtdIns lipid involved in the regulation of Ser 1490 phosphorylation.
We used a rapidly inducible PtdIns (4,5)P 2 hydrolysis system to further investigate the role of PtdIns (4,5)P 2 in regulating phosphorylation of LRP6. In this system, rapamycin induces the heterodimerization of membrane-targeted FRP (fragment of mammalian target of rapamycin that binds FKBP12) and FKBP12 (FK560-binding protein 12) fused with a truncated form of type IV phosphoinositide 5-phosphatase, leading to activation of the phosphatase (15, 16) . As shown in Fig. 2D , rapamycin reduced the amount of PtdIns (4,5)P 2 in cells expressing both FRP and phosphatasefused FKBP12, but not in those expressing FRP and FKBP12 alone. Rapamycin also attenuated phosphorylation of LRP6 only in cells expressing both FRP and phosphatase-fused FKBP12 ( Fig. 2E) .
To determine whether Wnt3a can stimulate PtdIns (4,5)P 2 production, we established a PtdIns (4,5)P 2 ELISA and detected significant Wnt3ainduced formation of PtdIns (4,5)P 2 (more than twofold increases) in HEK293T, Hela, and NIH3T3 cells ( fig. S4A ). We confirmed these results by highperformance liquid chromatography (HPLC) and thin-layer chromatography (TLC) (Fig. 3A and fig.  S4 , B and C). Together with the findings that the PI4KIIa siRNA abolished (and the PIP5KIb siRNA (Fig. 3B ), we conclude that Wnt3a stimulates PtdIns (4,5)P 2 production via these PtdIns kinases.
We next investigated whether Fz is required for Wnt3a-induced formation of PtdIns (4,5)P 2 and detected expression of Fz2, 3, 4, 5, and 6 in HEK293Tcells by reverse transcription polymerase chain reaction (table S2) . We made and validated two sets of siRNAs for each of these Fz genes (table  S2) . Fz5 siRNA showed the strongest inhibition of Wnt3a-induced accumulation of b-catenin, whereas Fz2 and Fz4 siRNAs also had some inhibitory effect ( fig. S5B and table S2 ). The combination of Fz2, 4, and 5 siRNAs virtually abolished Wnt3ainduced accumulation of b-catenin (table S2) . This combination also abrogated Wnt3a-induced forma-tion of PtdIns (4,5)P 2 (Fig. 3C ) and phosphorylation of LRP6 at Ser 1490 (Fig. 3D, fig. S5C, and  table S2 ). On the other hand, expression of Fz5, 2, and 4 stimulated the formation of PtdIns (4,5)P 2 (Fig. 3E) and Wnt3a-induced phosphorylation of Ser 1490 (Fig. 3F, and fig. S5 , D and E). These results together indicate that Wnt3a acts through Fz to stimulate PtdIns (4,5)P 2 formation in HEK293T cells and regulates LRP6 phosphorylation.
Because dishevelled (Dvl) is required for the phosphorylation of LRP6 (9, 10), we questioned whether Dvl might have a role in the formation of PtdIns (4,5)P 2 . Expression of Dvl1-3 increased the amount of PtdIns (4,5)P 2 in HEK293T cells (Fig.  3G and fig. S6A ). When HEK293T cells were transfected with a mixture of three Dvl siRNAs tar-geting each of the three Dvl isoforms (17) , both Wnt3a-induced formation of PtdIns (4,5)P 2 and phosphorylation of Ser 1490 were inhibited (Fig. 3, H  and I, and fig. S6B ). Dvl is a scaffold protein with no known enzymatic domains. We tested whether Dvl and PIP5KIb interacted and found that they coimmunoprecipitated when overexpressed in HEK293T cells ( fig. S6C ). We mapped Dvl interaction site to the N-terminal half of PIP5KIb kinase domain ( fig. S6D ) and PIP5KI-binding sites to two fragments of Dvl1 that contain the DIX and PDZ domain, respectively (fig. S6E ). The interaction of Dvl3 and PIP5KIb was also examined in a HEK293T cell line that stably expressed Dvl3 carrying seven hemagglutinin (HA) tags at its C terminus at a level lower than that of endogenous Dvl3 Fig. 3 . Stimulation of PtdIns (4,5)P 2 formation by Wnt3a through Fz and Dvl. (A) Effect of Wnt3a treatment on PtdIns (4,5)P 2 content. HEK293T Cells were stimulated with Wnt3a protein (50 ng/ml) before lipid extraction. PtdIns (4,5)P 2 content was determined by HPLC. *P < 0.01 compared with time 0 (Student's t test). (B) Requirement of PI4KIIa and PIP5KIb for Wnt3a-induced formation of PtdIns (4,5)P 2 . Cells were transfected with siRNAs, as indicated, for 48 hours and then treated with Wnt3a (50 ng/ml) for 30 min. PtdIns (4,5)P 2 were detected by ELISA. (C) Effect of Fz siRNAs on Wnt3ainduced formation of PtdIns (4,5)P 2 . Cells were transfected with control siRNA or a combination of Fz2, Fz4, and Fz5 siRNAs for 48 hours and then treated with Wnt3a (50 ng/ml) for 30 min before assays. *P < 0.01 compared with control siRNA transfection in the absence of Dvl3 proteins for 2 hours at room temperature. One-tenth of the samples was taken for Western blotting, and the rest was subjected to in vitro kinase assay with PtdIns (4)P as a substrate. The product PtdIns (4,5)P 2 is separated by TLC, detected, and quantified by a phosphoimager. Error bars indicate SDs in all panels. Fig. 3J ). Although we did not observe coimmunoprecipitation in the absence of Wnt3a, an interaction of Dvl3-HA with endogenous PIP5KIb was detected in the presence of Wnt3a (Fig. 3J ), suggesting that Wnt3a may regulate the interaction. In a pull-down assay with recombinant proteins prepared in E. coli, Dvl1 interacted with PIP5KIb and Ia in vitro ( fig. S6F ). We then tested whether Dvl could directly regulate PIP5KI kinase activity. Using the recombinant Dvl3 and PIP5KIb prepared from E. coli, we found that, in an in vitro kinase assay, Dvl directly stimulated PIP5KIb in a dose-dependent manner ( Fig. 3K and fig. S6G ). Together with the knowledge that Fz can interact with Dvl and recruit it to the membranes (9, 18-23), the above data suggest that Wnt3a may induce (through Fz) Dvl to bind and activate PIP5KI.
We next tested whether PtdIns (4,5)P 2 is required for Wnt3a-induced formation of LRP6 aggregates (referred to as "signalosomes"), which precedes phosphorylation of LRP6 at Thr 1479 (9) . We used sucrose density-gradient centrifugation to detect LRP6 aggregates (Fig. 4A ). Fractions that contained LRP6 aggregates also had a higher PtdIns (4,5)P 2 content than did fractions containing nonaggregated LRP6 (Fig. 4B) . Notably, the aggregation was sensitive to the elimination of PtdIns (4,5)P 2 through rapamycin-induced PtdIns (4,5)P 2 hydrolysis (Fig. 4A ). We also examined LRP6 aggregation using confocal microscopy in Hela cells expressing LRP6-YFP (9) . We observed the aggregates in control cells but not in cells transfected with the PIP5KI siRNAs ( fig. S7 ). Elimination of PtdIns (4,5)P 2 also led to decreased phosphorylation of Thr 1479 (Fig. 4C) (9) . Therefore, we conclude that PtdIns (4,5)P 2 is required for Wnt-induced LRP6 aggregation and Thr 1479 phosphorylation.
Because LRP6 aggregates appear to have a high affinity for axin (9) and because axin membrane translocation is required for GSK3-mediated phosphorylation of Ser 1490 (10), we examined if PtdIns (4,5)P 2 is involved in Wnt-induced axin membrane translocation. Elimination of PtdIns (4,5)P 2 using the rapamycin-inducible PtdIns (4,5)P 2 hydrolysis system abrogated Wnt3a-induced axin translocation (Fig. 4D ). Putting all of these results together, we propose a model (Fig. 4E ) to suggest that Wnt3a regulates the activity of PIP5KI through Fz and Dvl and induces the formation of PtdIns (4,5)P 2 . PtdIns (4,5)P 2 is required, but not sufficient, for LRP6 aggregation and phosphorylation at both Thr 1479 and Ser 1490 , as well as for axin translocation. Precise mechanisms by which PtdIns (4,5)P 2 regulates these Wnt signaling events, however, need to be investigated further.
